FAVATA, FABIO
FAVATA, FABIO
SCIENZE MEDICHE
A UHPLC-MS/MS method for the quantification of currently used direct antiviral agents in human plasma and evaluation of "normalized matrix effect"
2016-01-01 D'Avolio, A.; Ariaudo, A.; Favata, F.; De Nicolò, A.; Simiele, M.; Boglione, L.; Carcieri, C.; Di Perri, G.
A UHPLC-MS/MS Method to Quantify Tacrolimus in Tissues: Standardization Based on the Real Volume of Cells
2016-01-01 Pensi, D.; De Nicolò, A.; Favata, F.; Pisciotta, C.; Di Perri, G.; D'Avolio, A.
Are detectable sofosbuvir trough concentrations predictive of virological failure during anti-HCV treatment? Preliminary evidences from the KINETI-C study
2017-01-01 De Nicolò, A.; Boglione, L.; Carcieri, C.; Cusato, J.; Mornese Pinna, S.; Favata, F.; Ariaudo, A.; Di Perri, G.; D’Avolio, A.
Pharmacokinetics of simeprevir and risk of skin reactions in patients with co-infection HIV/HCV with or without a protease inhibitor containing HAART
2016-01-01 Marinaro, L.; Barco, A.; Vendemiati, G.; Merli, M.; Alcantarini, C.; Patti, F.; Airaudo, A.; Favata, F.; Milesi, M.; Cusato, J.; Tettoni, M.C.; Trentini, L.; Hasson, H.; Uberti Foppa, C.; D'Avolio, A.; Di Perri, G.; Bonora, S.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A UHPLC-MS/MS method for the quantification of currently used direct antiviral agents in human plasma and evaluation of "normalized matrix effect" | 2016 | D'Avolio, A.; Ariaudo, A.; Favata, F.; De Nicolò, A.; Simiele, M.; Boglione, L.; Carcieri, C.; Di Perri, G. | |
| A UHPLC-MS/MS Method to Quantify Tacrolimus in Tissues: Standardization Based on the Real Volume of Cells | 2016 | Pensi, D.; De Nicolò, A.; Favata, F.; Pisciotta, C.; Di Perri, G.; D'Avolio, A. | |
| Are detectable sofosbuvir trough concentrations predictive of virological failure during anti-HCV treatment? Preliminary evidences from the KINETI-C study | 2017 | De Nicolò, A.; Boglione, L.; Carcieri, C.; Cusato, J.; Mornese Pinna, S.; Favata, F.; Ariaudo, A.; Di Perri, G.; D’Avolio, A. | |
| Pharmacokinetics of simeprevir and risk of skin reactions in patients with co-infection HIV/HCV with or without a protease inhibitor containing HAART | 2016 | Marinaro, L.; Barco, A.; Vendemiati, G.; Merli, M.; Alcantarini, C.; Patti, F.; Airaudo, A.; Favata, F.; Milesi, M.; Cusato, J.; Tettoni, M.C.; Trentini, L.; Hasson, H.; Uberti Foppa, C.; D'Avolio, A.; Di Perri, G.; Bonora, S. |